NM_006950.3:c.1056-14_1056-8delCTTTGTC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_006950.3(SYN1):​c.1056-14_1056-8delCTTTGTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,200,263 control chromosomes in the GnomAD database, including 11 homozygotes. There are 385 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 3 hom., 174 hem., cov: 23)
Exomes 𝑓: 0.00070 ( 8 hom. 211 hem. )

Consequence

SYN1
NM_006950.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.09

Publications

1 publications found
Variant links:
Genes affected
SYN1 (HGNC:11494): (synapsin I) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
SYN1 Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, X-linked 1, with variable learning disabilities and behavior disorders
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-47576240-AGACAAAG-A is Benign according to our data. Variant chrX-47576240-AGACAAAG-A is described in ClinVar as Benign. ClinVar VariationId is 199183.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00574 (646/112452) while in subpopulation AFR AF = 0.0194 (600/30967). AF 95% confidence interval is 0.0181. There are 3 homozygotes in GnomAd4. There are 174 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYN1NM_006950.3 linkc.1056-14_1056-8delCTTTGTC splice_region_variant, intron_variant Intron 8 of 12 ENST00000295987.13 NP_008881.2
SYN1NM_133499.2 linkc.1056-14_1056-8delCTTTGTC splice_region_variant, intron_variant Intron 8 of 12 NP_598006.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYN1ENST00000295987.13 linkc.1056-14_1056-8delCTTTGTC splice_region_variant, intron_variant Intron 8 of 12 2 NM_006950.3 ENSP00000295987.7
SYN1ENST00000340666.5 linkc.1056-14_1056-8delCTTTGTC splice_region_variant, intron_variant Intron 8 of 12 1 ENSP00000343206.4
ENSG00000283743ENST00000638776.2 linkn.3512-14_3512-8delCTTTGTC splice_region_variant, intron_variant Intron 14 of 15 5

Frequencies

GnomAD3 genomes
AF:
0.00569
AC:
640
AN:
112397
Hom.:
3
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0192
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00596
GnomAD2 exomes
AF:
0.00176
AC:
281
AN:
159843
AF XY:
0.00107
show subpopulations
Gnomad AFR exome
AF:
0.0197
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000435
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.000700
AC:
762
AN:
1087811
Hom.:
8
AF XY:
0.000594
AC XY:
211
AN XY:
355325
show subpopulations
African (AFR)
AF:
0.0197
AC:
515
AN:
26186
American (AMR)
AF:
0.00207
AC:
70
AN:
33835
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19195
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29744
South Asian (SAS)
AF:
0.000304
AC:
16
AN:
52620
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39796
Middle Eastern (MID)
AF:
0.000970
AC:
4
AN:
4123
European-Non Finnish (NFE)
AF:
0.0000239
AC:
20
AN:
836579
Other (OTH)
AF:
0.00300
AC:
137
AN:
45733
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00574
AC:
646
AN:
112452
Hom.:
3
Cov.:
23
AF XY:
0.00503
AC XY:
174
AN XY:
34610
show subpopulations
African (AFR)
AF:
0.0194
AC:
600
AN:
30967
American (AMR)
AF:
0.00328
AC:
35
AN:
10682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3579
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2756
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6168
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53219
Other (OTH)
AF:
0.00589
AC:
9
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00278
Hom.:
7
Bravo
AF:
0.00733

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 30, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 16, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

SYN1-related disorder Benign:1
Aug 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 11, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377385507; hg19: chrX-47435639; API